| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/13/2007 | WO2007121411A3 Glucagon-like peptide 1(glp-1) pharmaceutical formulations |
| 12/13/2007 | WO2007117923A3 Compositions including relatively water insoluble/unwettable drugs and methods for using same |
| 12/13/2007 | WO2007110152A8 Polylactide nanoparticles |
| 12/13/2007 | WO2007109564A3 Yeast cell particles as oral delivery vehicles for antigens |
| 12/13/2007 | WO2007109104A3 Modified release formulations containing drug-ion exchange resin complexes |
| 12/13/2007 | WO2007105171A3 Killing of selected cells |
| 12/13/2007 | WO2007104549A8 Bioresorbable controlled-release composition |
| 12/13/2007 | WO2007098924A3 Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof |
| 12/13/2007 | WO2007098446A3 Method for minimizing variation in dosage forms |
| 12/13/2007 | WO2007098106A3 Respiratory tract delivery of interferon-tau |
| 12/13/2007 | WO2007090987A8 Palatable support with an improved formula |
| 12/13/2007 | WO2007090882A3 Pharmaceutical extended release compositions comprising pramipexole |
| 12/13/2007 | WO2007090097A3 Systems and methods for targeted and controlled delivery of agents |
| 12/13/2007 | WO2007089864A3 Sutures and fibrosing agents |
| 12/13/2007 | WO2007087188A3 Taste-masked tablets and granules |
| 12/13/2007 | WO2007086078A3 Novel pharmaceutical compositions and process of preparation thereof |
| 12/13/2007 | WO2007077529A3 Oral, pulmonary and transmucosal delivery composition |
| 12/13/2007 | WO2007075475A3 Gastric reflux resistant dosage forms |
| 12/13/2007 | WO2007072461A3 Modified proteins comprising a bioactive peptide/protein linked to a sequence of aminoacids containing a human carbohydrate binding module (cbm), and development of a system for the administration of therapeutically active proteins and respective utilizations for biomedical purposes |
| 12/13/2007 | WO2007037795A3 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 12/13/2007 | WO2006113568A8 Controlled delivery dosage form of tramadol and gabapentin |
| 12/13/2007 | WO2006095026A8 New soft gelatin capsules |
| 12/13/2007 | WO2006060027A3 A method for improvement of tolerance for therapeutically effective agents delivered by inhalation |
| 12/13/2007 | WO2006033779A3 Energetically controlled delivery of biologically active material from an implanted medical device |
| 12/13/2007 | WO2005034852A3 Protein biomaterials and biocoacervates and methods of making and using thereof |
| 12/13/2007 | WO2003101600A3 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion |
| 12/13/2007 | WO2003037306A3 Inhalation of vapour of therapeutical substances, like e.g. cannabis extract |
| 12/13/2007 | US20070287991 Devices and methods for detection of markers of axial pain with or without radiculopathy |
| 12/13/2007 | US20070287985 Medication delivery system and monitor |
| 12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |
| 12/13/2007 | US20070287969 Microinfusion device |
| 12/13/2007 | US20070287949 Transdermal System for Sustained Delivery of Polypeptides |
| 12/13/2007 | US20070287826 Production of high molecular mass lectins |
| 12/13/2007 | US20070287800 Lubricious Compounds For Biomedical Applications Using Hydrophilic Polymers |
| 12/13/2007 | US20070287791 Polymer compositions containing surface-modified non-halogenated mineral fillers |
| 12/13/2007 | US20070287749 Bromfenac ophthalmic formulations and methods of use |
| 12/13/2007 | US20070287722 Drop Preparations Comprising Dimetindene |
| 12/13/2007 | US20070287714 Warming and Nonirritating Lubricant Compositions and Method of Comparing Irritation |
| 12/13/2007 | US20070287682 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070286904 Structured materials |
| 12/13/2007 | US20070286903 Composition and method for taste masking |
| 12/13/2007 | US20070286902 Dosage forms comprising a short acting sedative-hypnotic or salt thereof |
| 12/13/2007 | US20070286901 Novel Pharmaceutical Formulation of Cefixime for Enhanced Bioavailability |
| 12/13/2007 | US20070286900 Low dose tablets of opioid analgesics and preparation process |
| 12/13/2007 | US20070286899 Photo-composition for the treatment of joint diseases |
| 12/13/2007 | US20070286898 Intracellular Drug Delivery Improving Liposome |
| 12/13/2007 | US20070286897 Liposomal Formulations of Anthracycline Agents and Cytidine Analogs |
| 12/13/2007 | US20070286896 Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome |
| 12/13/2007 | US20070286894 Lotioned wipe product to reduce adhesion of soils or exudates to the skin |
| 12/13/2007 | US20070286893 Lotioned wipe product comprising an anti-stick agent and a performance enhancing agent |
| 12/13/2007 | US20070286892 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals |
| 12/13/2007 | US20070286890 Eyelash applicator and method |
| 12/13/2007 | US20070286889 Weight management system for obese animals |
| 12/13/2007 | US20070286886 Materials And Methods For Inducing Apoptosis In Adipocytes |
| 12/13/2007 | US20070286881 Method, composition and kit for treating degenerated disc disease and discogenic pain |
| 12/13/2007 | US20070286880 Inoculated spongiform scaffold for transplantation and tissue regeneration |
| 12/13/2007 | US20070286878 Removable films for sanitizing substrates and methods of use thereof |
| 12/13/2007 | US20070286877 Multi-functional protective textiles and methods for decontamination |
| 12/13/2007 | US20070286876 Skin care compositions comprising low concentrations of skin treatment agents |
| 12/13/2007 | US20070286875 Oral liquid loratadine formulations and methods |
| 12/13/2007 | US20070286821 Composition with activated carbon in oral treatment |
| 12/13/2007 | US20070286819 Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability |
| 12/13/2007 | US20070286818 Treating cystic fibrosis with antibiotics via an aerosol drug |
| 12/13/2007 | US20070286817 Treating cystic fibrosis with antibiotics via a swirler delivery |
| 12/13/2007 | US20070286816 Drug and excipient aerosol compositions |
| 12/13/2007 | US20070286815 Medicinal Aerosol Formulations and Methods of Synthesizing Ingredients Therefor |
| 12/13/2007 | US20070286814 Stable aerosol pharmaceutical formulations |
| 12/13/2007 | US20070286813 Nasal formulation |
| 12/13/2007 | US20070286812 Nasal formulation |
| 12/13/2007 | US20070286811 Method for the manufacturing of a diffraction grating structure on the surface of pharmaceutical tablet |
| 12/13/2007 | DE19529057B4 Ifosfamid-Lyophilisat-Zubereitungen Ifosfamide lyophilized preparations |
| 12/13/2007 | CA2690058A1 Fermented probiotic beverages and uses thereof |
| 12/13/2007 | CA2689862A1 Probiotic compositions comprising propionibacterium and uses thereof |
| 12/13/2007 | CA2665034A1 Methods for treating a urethral stricture with a botulinum toxin |
| 12/13/2007 | CA2654631A1 Modulation of the immune system by inositol phospholipids |
| 12/13/2007 | CA2654593A1 Functionalized, solid polymer nanoparticles for diagnostic and therapeutic applications |
| 12/13/2007 | CA2654512A1 Low dose sublingual tablets of opioid analgesics and preparation process |
| 12/13/2007 | CA2654457A1 Fermented milk product and use thereof |
| 12/13/2007 | CA2654361A1 Delayed-release compositions of extended release forms of venlafaxine |
| 12/13/2007 | CA2654152A1 Method of treating atrophic vaginitis |
| 12/13/2007 | CA2654082A1 Use of micron-sized sulphur for the prevention and treatment of pathogenic disorders in humans and animals |
| 12/13/2007 | CA2653955A1 Pharmaceutical compositions for sustained release of phenylephrine |
| 12/13/2007 | CA2653953A1 Phenylephrine pharmaceutical formulations and compositions for colonic absorption |
| 12/13/2007 | CA2653950A1 Phenylephrine pulsed release formulations and pharmaceutical compositions |
| 12/13/2007 | CA2653936A1 Sustained release pharmaceutical dosage form containing phenylephrine |
| 12/13/2007 | CA2653827A1 Novel blonanserin tape preparation |
| 12/13/2007 | CA2653625A1 Controlled release formulations |
| 12/13/2007 | CA2653596A1 Disposable infusion device with linear peristaltic pump |
| 12/13/2007 | CA2653537A1 Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic |
| 12/13/2007 | CA2653504A1 Nanoparticulate posaconazole formulations |
| 12/13/2007 | CA2653485A1 Prednisolone salt formulations |
| 12/13/2007 | CA2653480A1 Prednisolone salt formulations |
| 12/13/2007 | CA2652712A1 Stabilized pharmaceutical compositions comprising fesoterodine |
| 12/13/2007 | CA2652620A1 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof |
| 12/13/2007 | CA2652222A1 Preparation of antibody- or antibody-fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 12/13/2007 | CA2652216A1 Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient flux |
| 12/13/2007 | CA2649372A1 Process for making multiparticulates using a roller compactor |
| 12/12/2007 | EP1864967A1 Method for preparing O-desmethyl-venlafaxine |
| 12/12/2007 | EP1864679A2 Improved bacterial outer membrane vesicles |